1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Chemcon Speciality Chemicals Ltd

Chemcon Speciality Chemicals Ltd

198.30
INR
-4.35
(-2.15%)
7.69EPS
24.31P/E
6.85BMarket Cap
Oct 24Next Earn
Chemcon Speciality Chemicals Ltd
BSE:CHEMCON
(Bombay Stock Exchange)

Recent

price

198.30

P/E

ratio

24.31

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
42.8
82.63
71.27
71.07
70.09
82.21
72.47
56.27
65.27
69.05
Revenue per Share
7.2
11.75
13.34
16.48
17.13
15.04
5.24
6.68
6.44
7.69
Basic EPS, GAAP
1.66
-0.88
-1
9.69
6.56
-9.13
-8.43
7.85
8.83
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
4
- -
- -
- -
- -
Dividend per Share
14.64
26.49
39.96
96.56
113.89
124.86
130.06
136.68
131.89
- -
Book Value per Share
14.64
26.48
39.95
96.55
113.89
124.86
130.05
136.68
131.89
- -
Tangible Book Value per Share
37
37
37
34
37
37
37
37
37
37
Basic Weighted Avg Shares
1,568
3,027
2,611
2,432
2,567
3,012
2,655
2,061
2,391
2,529
Sales/Revenue/Turnover
27.45
20.88
25.29
31.12
29.62
20.7
6.24
10.89
8.03
9.99
Operating Margin (%)
23
29
46
61
63
84
103
105
116
126
Depreciation Expense
264
430
489
564
628
551
192
245
236
282
Net Income, GAAP
34.94
29.68
24.75
25.85
25.29
25.68
26.9
26.23
26.16
26.01
Effective Tax Rate (%)
16.83
14.22
18.71
23.19
24.44
18.29
7.23
11.86
9.87
11.14
Profit Margin (%)
269
605
1,109
2,443
2,982
2,201
2,895
2,714
2,675
- -
Working Capital
25
25
154
29
8
7
4
2
5
- -
LT Debt
536
970
1,464
3,537
4,172
4,574
4,764
5,007
4,831
- -
Total Equity
- -
43.48
30.66
20.06
13.77
9.59
2.33
3.16
2.65
- -
Return on Invested Capital (%)
- -
44.91
31.89
21.38
15.54
11.53
4.17
5.17
4.72
- -
Return on Capital (%)
- -
57.14
40.14
22.56
16.28
12.6
4.11
5.01
4.8
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
531
- -
LT Borrowings
- -
1
- -
LT Finance Leases
- -
4
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
7,427
4,619
6,850

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,460
- -
Cash, Cash Equivalents & STI
- -
657
- -
Accounts Receivable, Net
- -
635
- -
Inventories
- -
673
- -
Total Current Liabilities
- -
785
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
531
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.67%
-3.5%
Free Cash Flow
- -
-90.98%
12.55%
Net Income, GAAP
- -
-8.43%
-3.49%
Sales/Revenue/Turnover
- -
0.93%
16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
455
526
544
549
2,061
2026
535
537
573
754
2,391
2027
665
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.47
1.73
2.4
1.08
6.68
2026
1.74
1.57
1.39
1.74
6.44
2027
2.99
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Chemcon Speciality Chemicals Limited operates as an Indian manufacturer specializing in pharmaceutical intermediates, silanes, and oilfield chemicals, including completion fluids. Founded in 1996 and headquartered in Vadodara, Gujarat, the company serves the pharmaceutical, silicone, electronics, and oilfield industries with products manufactured in compliance with GMP guidelines. Its core product portfolio includes pharmaceutical intermediates, completion brines, calcium bromide powder, zinc and calcium bromide mixtures, silanes, and specialty chemicals tailored for oilfield applications. The company holds ISO 9001:2015 and ISO 14001:2015 certifications for quality and environmental management. In recent developments, Chemcon completed the acquisition of Shivam Petrochem Industries’ business through a slump sale agreement valued at approximately INR 36 crore, enhancing its operational scale and product offerings. The firm expanded its production capacity of completion fluids to 18,000 tons per annum and commenced production of Completion Dry 14.2 (Calcium Bromide powder) with a capacity of 3,500 tons per annum. It appointed Mr. Neel Shah as an additional independent director and approved material related party transactions with the acquired Shivam Petrochem Industries, which is part of its promoter group. The company’s strategic focus remains on in-house process development for bromination and hydrochlorination technologies, maintaining leadership in the Indian market for products like Hexamethyldisilazane. Chemcon actively pursues new product development to support sustainable and efficient farming, alongside pharmaceutical and specialty chemical markets across India and selected international clients. Its sustained partnerships with major multinational pharmaceutical companies underline its strong market presence and commitment to high-quality product supply and timely delivery.